ArticleJournal of pain research2025
The Efficacy of CT-Guided Pulsed Radiofrequency of the Dorsal Root Ganglion Combined with Methylene Blue Sympathetic Injection on Herpes-Zoster Neuralgia: A Retrospective Study.
Article in Journal of pain research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Effects of Esketamine Infusion by Patient-Controlled Intravenous Analgesia in Patients With Zoster-Associated Pain: A Retrospective Study.Medical science monitor : international medical journal of experimental and clinical research · 2026Article
- CT-Guided Dorsal Root Ganglion Pulsed Radiofrequency Alone, with Ozone, or with Platelet-Rich Plasma for Postherpetic Neuralgia: A Randomized Controlled Trial.Journal of pain research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to investigate the efficacy of Computed Tomography (CT) Guided Pulsed Radiofrequency (PRF) of the Dorsal Root Ganglion (DRG) combined with Methylene Blue (MB) sympathetic injection in acute herpes zoster neuralgia. Background: MB is a nitric oxide synthesis inhibitor that has been reported to exert analgesic and anti-inflammatory properties. In this study, MB was injected to the thoracic or lumbar sympathetic nerve to inhibit sympathetic nerve conduction or destroy nerve endings. This is the first report for thoracic or lumbar sympathetic nerve MB injection. Materials and Methods: 64 patients in study were divided into two groups: PRF combined with sympathetic nerves MB injection group (group A; n = 32,); PRF group (group B; n = 32). The therapeutic effects of each group were compared using the Numeric Rating Scale (NRS) scores and the average doses of Pregabalin (mg/d) immediately after surgery (T1) and at one month (T2), three months (T3), six months (T4), nine months (T5), and twelve months (T6) post-operation. The incidence of postherpetic neuralgia (PHN) and complications in the two groups were observed and enrolled. Results: No significant differences in general conditions between the two groups. Compared with the preoperative baseline scores (T0), the NRS at T1 to T6 were significantly decreased in both groups. NRS was lower at T1 to T6 in the group A compared with the same times points in group B (P< 0.05). The incidences of PHN in group A were significantly lower at T3 to T6 compared with group B. The daily doses of pregabalin was lower in the A group than B group at T1 to T5, and it was not significantly different at T6 between the two groups. Finally, no adverse complications were recorded in both groups. Conclusion: CT-Guided PRF Combined with MB sympathetic Injection in the treatment of HZ neuralgia is safe and effective, reducing PHN.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.